16 March 2009
Singapore,UK Researchers discuss new ways to fight microbes, prevent vision loss
Download this press release Adobe Acrobat Document

Prof Sir David Lane, Chairman of A*STAR's Biomedical Research Council and Chief Scientist of Cancer Research UK, well known as the co-discoverer of the tumour suppressor gene, p53, will deliver the keynote address at the symposium organised jointly by A*STAR's Bioinformatics Institute, the Singapore Eye Research Institute and the British High Commission at Biopolis today.  His address will highlight a novel method of producing antibodies against the Dengue virus.

The two-day symposium is the 24th to be held here under the auspices of the "UK-Singapore Partners in Science" Programme.  Besides showcasing the latest and best in antimicrobial research, it is intended to foster international and interdisciplinary collaborations which will result in new synergies for healthcare. Said Dr Chandra Verma, Senior Research Scientist at the Bioinformatics Institute and symposium coordinator, "This symposium aims to bring together researchers at the forefront of infectious disease, who will exchange new knowledge and discoveries, as well as foster collaborations on novel antimicrobial therapies."

Feedback Login Site Map